Showing results (1-10 of 138) with videos related to
Sort By:
Pageof 14
Drug Discovery Today|August 15, 2015
Identifying compound efficacy targets in phenotypic drug discoveryMarkus Schirle, Jeremy L JenkinsTrends in Pharmacological Sciences|March 21, 2020
Characterizing Drug-Target Interactions: Shifting towards the ClinicMarkus SchirleJournal of Hematotherapy & Stem Cell Research|February 20, 2003
Identification of tumor-associated HLA-ligands in the post-genomic eraMarkus SchirleChemistry & Biology|January 31, 2012
Mass spectrometry-based proteomics in preclinical drug discoveryMarkus Schirle, Marcus Bantscheff, Bernhard KusterMolecular Informatics|August 2, 2016
Large-Scale QSAR in Target Prediction and Phenotypic HTS AssessmentJeremy L JenkinsMolecular & Cellular Proteomics : MCP|October 9, 2003
Profiling core proteomes of human cell lines by one-dimensional PAGE and liquid chromatography-tandem mass spectrometryMarkus Schirle, Marie-Anne Heurtier, Bernhard KusterNature Reviews. Molecular Cell Biology|June 16, 2005
Scoring proteomes with proteotypic peptide probesBernhard Kuster, Markus Schirle, Parag Mallick, et al.Molecular Biology of the Cell|September 10, 2004
Arf1p provides an unexpected link between COPI vesicles and mRNA in Saccharomyces cerevisiaeMark Trautwein, Jörn Dengjel, Markus Schirle, et al.Methods in Molecular Biology (Clifton, N.J.)|September 4, 2009
Chemogenomic analysis of safety profiling dataJosef Scheiber, Jeremy L JenkinsBiochemistry|June 5, 2003
Identification of small-molecule inhibitors of human angiogenin and characterization of their binding interactions guided by computational dockingJeremy L Jenkins, Robert ShapiroPageof 14